Dr. Peter W. Schiller, PhD
Montreal Clinical Research Institute
Biography & Research Background
Peter W. Schiller, PhD, is a researcher at the Montreal Clinical Research Institute (IRCM) and co-discoverer of elamipretide. He designed and chemically synthesized the SS peptide analogs in collaboration with Dr. Szeto, and developed the fluorescent peptide derivatives that enabled visualization of mitochondrial localization — a key methodological breakthrough that confirmed the SS-31 mechanism of action. His expertise in peptide chemistry and structure-activity relationships was foundational to the development of the aromatic-cationic structural motif that gives SS-31 its selective mitochondrial targeting properties. Key publications include the original SS peptide characterization studies. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Peter W. Schiller, PhD is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Peter W. Schiller, PhD is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.